Cargando…

Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement

INTRODUCTION: Gout is the most common inflammatory arthritis, but was not considered in most COVID-19 and rheumatic diseases reports. Our aim was to describe changes in clinical data, treatment, function and quality of life for gout patients during COVID-19 pandemic. METHODS: Prospective, descriptiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Maturano, Juan Salvador, Torres-Ordaz, David Eduardo, Mosqueda-Gutiérrez, Miguel, Gómez-Ruiz, Citlallyc, Vázquez-Mellado, Aarón, Tafoya-Amado, Alicia, Peláez-Ballestas, Ingris, Burgos-Vargas, Rubén, Vázquez-Mellado, Janitzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613459/ https://www.ncbi.nlm.nih.gov/pubmed/34822044 http://dx.doi.org/10.1007/s10067-021-05994-z

Ejemplares similares

A Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article
por: García-Méndez, Sergio, et al.
Publicado: (2015)

Coping Strategies for Health and Daily-Life Stressors in Patients With Rheumatoid Arthritis, Ankylosing Spondylitis, and Gout: STROBE-Compliant Article
por: Peláez-Ballestas, Ingris, et al.
Publicado: (2015)

Entheseal Involvement in Spondyloarthritis (SpA) and Gout: An Ultrasound Comparative Study
por: Ventura-Ríos, Lucio, et al.
Publicado: (2022)

Epidemiology of rheumatic diseases in indigenous populations in Latin-Americans
por: Peláez-Ballestas, Ingris, et al.
Publicado: (2016)

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
por: Uhlig, T., et al.
Publicado: (2022)

Occasional presence of herpes viruses in synovial fluid and blood from patients with rheumatoid arthritis and axial spondyloarthritis
por: Burgos, Rubén, et al.
Publicado: (2015)

Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
por: Stamp, Lisa K., et al.
Publicado: (2022)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
por: Pang, Lei, et al.
Publicado: (2023)

When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy
por: Choi, Hyon K., et al.
Publicado: (2022)

Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism
por: Méndez-Salazar, Eder Orlando, et al.
Publicado: (2021)

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout
por: Murdoch, Rachel, et al.
Publicado: (2021)

Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study: MSU burden and risk of gout flare
por: Pascart, Tristan, et al.
Publicado: (2018)

Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
por: Flynn, Tanya J, et al.
Publicado: (2015)

Long-term safety of pegloticase in chronic gout refractory to conventional treatment
por: Becker, Michael A, et al.
Publicado: (2013)

Urate in fingernail represents the deposition of urate burden in gout patients
por: Chen, Haibing, et al.
Publicado: (2020)

A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
por: Burgos-Vargas, Rubén, et al.
Publicado: (2022)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
por: Baraf, Herbert SB, et al.
Publicado: (2013)

Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study
por: Hu, Shuhui, et al.
Publicado: (2022)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis
por: Morillon, Melanie B, et al.
Publicado: (2016)

Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
por: Sun, Mengying, et al.
Publicado: (2018)

The relationship between ferritin and urate levels and risk of gout
por: Fatima, Tahzeeb, et al.
Publicado: (2018)

Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
por: Tan, Philip K., et al.
Publicado: (2016)

Purinergic Signaling in the Regulation of Gout Flare and Resolution
por: Li, Xiaoling, et al.
Publicado: (2021)

Development and validation of a questionnaire to assess delay in treatment for breast cancer
por: Unger-Saldaña, Karla, et al.
Publicado: (2012)

The challenges of gout flare reporting: mapping flares during a randomized controlled trial
por: Teoh, Novell, et al.
Publicado: (2019)

Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
por: Lee, You-Hyun, et al.
Publicado: (2006)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017)

Clinical Image: In vivo urate spherulites in a patient with gout
por: Pirker, Ian, et al.
Publicado: (2021)

Replication of Gout/Urate Concentrations GWAS Susceptibility Loci Associated with Gout in a Han Chinese Population
por: Li, Zhiqiang, et al.
Publicado: (2017)

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment
por: Abhishek, Abhishek, et al.
Publicado: (2022)

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout
por: Terkeltaub, Robert, et al.
Publicado: (2019)

Urate-lowering treatment and risk of total joint replacement in patients with gout
por: Kuo, Chang-Fu, et al.
Publicado: (2018)

Effects of multiple genetic loci on the pathogenesis from serum urate to gout
por: Dong, Zheng, et al.
Publicado: (2017)

Slowly melting the urate snow in joints: Explaining gout attacks to patients
por: Shimizu, Toru, et al.
Publicado: (2021)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease
por: Chang, Hongtao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vqjk0kis7tq8kngn1d5qc5v51